Socioeconomic impact of treatment with biological disease-modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis.

In this study of Japanese patients with rheumatoid arthritis, the socioeconomic burden increased across patient groups and drug classes. Decrease in indirect (loss of productivity) costs partially offset the increase in direct costs.